Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2011

View Archived Issues

Esmirtazapine may impair day-after driving performance

Yokukansan ameliorates aspects of two autism spectrum disorders

SHIFT substudy evaluates ivabradine in patients on background therapy for heart failure

Doxazosin versus tizanidine assessed in children with voiding dysfunction

Merck & Co. reports discovery of new tachykinin NK1 receptor antagonists

EVOLVE-1 trial assesses mTOR inhibitor plus best supportive care in hepatocellular carcinoma

Merck KGaA presents novel TGFR-1 inhibitors

KBP Biosciences patents novel antibacterial prodrugs of carbapenem derivatives

New prostaglandin E synthase inhibitors synthesized

Elevation Pharmaceuticals begins phase II trial of nebulized EP-101 in COPD

New substituted trifluoromethanes disclosed

Completed phase IIa study provides promising data on VX-509 in rheumatoid arthritis

Durect advances U.S. phase III Posidur trial

Adolor completes reacquisition of all rights to alvimopan

BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone

RIKEN identifies novel IFN-gamma inducers

Discovery Labs submits complete response to FDA for Surfaxin

Theratechnologies initiates new phase II tesamorelin study

Boehringer Ingelheim provides updates on two phase II afatinib trials in breast cancer

Basilea Pharmaceutica begins second phase I trial of sulfactam antibiotic BAL-30072

Furiex reports promising phase II data on MuDelta in D-IBS

SARcode BioScience initiates phase III trial of SAR-1118 ophthalmic solution

European Commission grants PUMA for Buccolam

AB Science commences enrollment in international masitinib trial in MS

MediGene and Pharmanova enter agreement for Veregen

University of Pennsylvania awards grant to OPKO for MPS I therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...